ArticleInternational journal of molecular sciences2024

Combined Use of Tocilizumab and Mesenchymal Stem Cells Attenuate the Development of an Anti-HLA-A2.1 Antibody in a Highly Sensitized Mouse Model.

Xianying Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.